.svg)
Solt DB is a public benefit company exploring the business of biotech with data, context, and nuance. The finch helps investors learn about science and scientists learn about business.
Subscriptions to investment research ensure our platform has long-term sustainability. That strong foundation allows us to create value for the public benefit.
The finch publishes free, objective analyses of the bioeconomy. We combine clear writing and data visualizations to make nerdy technical concepts accessible, so you can go beyond the headlines on a noisy internet. We're also developing high quality, open source data assets such as the Solt DB Biotech Company Database, which provides the most granular historical record of global biotech companies. Our unique business model means our incentives are never tied to advertising, clickbait, or corporate sponsors.
We don't tell you about biotech. We show you.
Solt DB leverages interactive data visualizations to discuss and analyze living technology in vivid detail. From individual company insights to broad trends across competitive landscapes, the finch helps you objectively understand the bioeconomy -- even when trends don't match the headlines.
Click or hover these charts to view data labels.
Solt DB uses the same illustration tools as scientists publishing in the world's top journals -- a first in finance.
The combination of simple language and clear visuals allows investors of all backgrounds to more deeply understand the biotech stocks they own, while scientists can gain a better grasp of the business of biotech.
Our premium subscription to investment research doesn't tell you every stock is a buy. Sometimes good businesses and promising technologies platforms are overvalued -- and it's okay to admit that.
Solt DB Invest quantifies written research with a real-time margin of safety, which shows how much stocks need to rise or fall to reach our modeled fair value.
This chart is interactive, too.
-cropped.svg)
.svg){kind=small}
.svg){kind=small}
.svg)